Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 13 studies | 60% ± 26% | |
GABAergic neuron | 11 studies | 45% ± 25% | |
oligodendrocyte precursor cell | 11 studies | 35% ± 13% | |
astrocyte | 9 studies | 26% ± 13% | |
retinal ganglion cell | 7 studies | 54% ± 22% | |
neuron | 6 studies | 40% ± 11% | |
interneuron | 6 studies | 47% ± 21% | |
cardiac muscle cell | 5 studies | 41% ± 12% | |
endothelial cell | 4 studies | 39% ± 22% | |
granule cell | 4 studies | 42% ± 10% | |
OFF-bipolar cell | 4 studies | 47% ± 16% | |
GABAergic interneuron | 3 studies | 45% ± 5% | |
ON-bipolar cell | 3 studies | 43% ± 11% | |
amacrine cell | 3 studies | 25% ± 8% | |
rod bipolar cell | 3 studies | 34% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 4405.74 | 2566 / 2642 | 99% | 28.39 | 699 / 705 |
adrenal gland | 85% | 1284.60 | 220 / 258 | 87% | 14.71 | 201 / 230 |
esophagus | 75% | 657.10 | 1082 / 1445 | 47% | 18.81 | 86 / 183 |
heart | 96% | 3516.04 | 826 / 861 | 0% | 0 | 0 / 0 |
uterus | 46% | 311.44 | 78 / 170 | 45% | 9.71 | 205 / 459 |
eye | 0% | 0 | 0 / 0 | 85% | 43.51 | 68 / 80 |
skin | 16% | 104.42 | 287 / 1809 | 68% | 18.92 | 319 / 472 |
tonsil | 0% | 0 | 0 / 0 | 80% | 15.40 | 36 / 45 |
intestine | 62% | 559.52 | 595 / 966 | 10% | 0.73 | 52 / 527 |
ovary | 58% | 374.12 | 105 / 180 | 6% | 0.38 | 26 / 430 |
bladder | 43% | 253.86 | 9 / 21 | 19% | 3.87 | 94 / 504 |
lung | 20% | 114.13 | 113 / 578 | 39% | 27.56 | 451 / 1155 |
muscle | 58% | 465.75 | 465 / 803 | 0% | 0 | 0 / 0 |
prostate | 47% | 302.84 | 114 / 245 | 5% | 0.22 | 25 / 502 |
blood vessel | 49% | 431.94 | 656 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 0% | 1.40 | 1 / 328 | 46% | 2.85 | 82 / 178 |
stomach | 19% | 130.77 | 69 / 359 | 14% | 1.15 | 40 / 286 |
breast | 15% | 80.90 | 67 / 459 | 14% | 0.71 | 158 / 1118 |
adipose | 28% | 165.47 | 338 / 1204 | 0% | 0 | 0 / 0 |
thymus | 13% | 72.04 | 85 / 653 | 4% | 0.43 | 25 / 605 |
liver | 0% | 0 | 0 / 226 | 10% | 1.56 | 40 / 406 |
kidney | 2% | 9.56 | 2 / 89 | 7% | 0.45 | 59 / 901 |
spleen | 4% | 18.81 | 9 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.12 | 1 / 29 |
peripheral blood | 2% | 24.17 | 17 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0007155 | Biological process | cell adhesion |
GO_0006508 | Biological process | proteolysis |
GO_0007417 | Biological process | central nervous system development |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0005178 | Molecular function | integrin binding |
Gene name | ADAM23 |
Protein name | Uncharacterized protein ADAM23 ADAM metallopeptidase domain 23 Disintegrin and metalloproteinase domain-containing protein 23 (ADAM 23) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3) (MDC-3) Metalloproteinase-disintegrin |
Synonyms | MDC3 |
Description | FUNCTION: May play a role in cell-cell and cell-matrix interactions. This is a non-catalytic metalloprotease-like protein. |
Accessions | ENST00000264377.8 [O75077-1] ENST00000374415.7 ENST00000444281.1 Q53RX4 E7EWD3 O75077 Q9UKK1 H7C2M6 Q53TK5 Q53TC0 |